Nolvadex is not an androgenic and non-anabolic steroid, it is a hormone that belongs to a series of triphenylethylenes (sexual hormones), a working chemical in this tamoxifen citrate preparation. Its effects affect the release of excess estrogen (a female hormone). After all, many anabolic steroids have the property of mutating into estrogens.
Often in prophylactic purposes it is quite enough if the athlete starts taking Nolvadex 3 to 4 weeks after the start of taking steroids. Athletes inclined to gynecomastia, a strong accumulation of water, increased accumulation of fat when taking Dianabol, Testosterone, Anapolon 50, Deca-Durabolin and other steroids, usually take 20 – 3 mg per day. The combined administration of 20 to 30 mg of Nolvadex and 25 to 50 mg of Proviron per day gives exceptionally good results. The same applies to athletes in the competition phase and women. Women should still refuse to take Nolvadex or lower their dose to 25 mg per day. A severely neglected gynecomastia does not respond in most cases to elimination with Nolvadex, so it often requires surgical intervention, often paid from the health insurance fund. The first signs of a possible gynecomastia are mild pain when you touch the nipples. Tablets are taken 1 to 2 times a day during meals, undiluted, washed down with liquid.
Of the pluses, this drug increases the production of its own testosterone, reduces the amount of estrogens in the body.
Of the minuses is that in some cases this drug may not reduce the content of estrogens, but on the contrary increase it, it also weakens the anabolic effect of certain steroids, as it reduces the level of estrogens, and some steroids act with a significant amount of estrogens in the body. This drug is very expensive, you can look for analogues of other companies to replace it and save money.
Side effects of this drug: at high dosages there is fever, vomiting, numbness, faintness, dullness of consciousness, visual impairment. If you do not exceed the dose of 30 mg per day, then the side effects are almost not observed.